Aflibercept monotherapy or bevacizumab first for diabetic macular edema

Aflibercept monotherapy or bevacizumab first for diabetic macular edema

Purpose: Clinical outcome and switch patterns with bevacizumab first treatment strategy for patients with newly diagnosed neovascular age-related macular degeneration (nAMD). Methods: Retrospective observational study of the number of intravitreal injections of bevacizumab and treatment switch in pa...

Full description

Bibliographic Details
Main Authors: Avner Hostovsky, Iris Moroz, Gabriel Katz
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Indian Journal of Ophthalmology
Subjects:
aflibercept
bevacizumab
intravitreal injection
ranibizumab
switch
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2024;volume=72;issue=14;spage=260;epage=264;aulast=Hostovsky

Internet

http://www.ijo.in/article.asp?issn=0301-4738;year=2024;volume=72;issue=14;spage=260;epage=264;aulast=Hostovsky

Similar Items